FDA Clearance Tracker · K211115
A1AT Genotyping Test
Last checked: Nov 21, 2026Latest source record: May 13, 2021 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2021
Substantially Equivalent
Time to decision
29 days
Received Apr 14, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K211115
- Device name
- A1AT Genotyping Test
- Applicant location
- Derio, ES
- Received
- Apr 14, 2021
- Decided
- May 13, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Serpina1 Variant Detection System (PZH)
- Device class
- Class II
- Regulation
- 21 CFR 866.5130
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PZH. The earliest in FDA's data is K171868, decided Nov 11, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K211115
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Progenika Biopharma S.A., A Grifols Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K221420 · Decided Oct 27, 2022 · 164 days after receipt
Device type: Genetic Variant Detection And Health Risk Assessment System (PTA) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.